BDSX - Company ID 0001439725
The table below shows BIODESIX INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$23.27M | -$48.65M | -$22.87M | -$44.97M | -$28.22M | -$21.37M |
| Capital expenditure | $259.00K | $3.23M | $22.92M | $3.30M | $2.24M | $1.95M |
| Investing cash flow | -$403.00K | -$3.44M | -$23.06M | -$3.53M | -$2.55M | -$2.93M |
| Dividends paid | - | - | - | - |
BIODESIX INC reported operating cash flow of -$23.27M for fiscal year 2025. That is up 52.2% from -$48.65M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$21.73M (FY 2019) to -$23.27M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $16.42M | $52.05M | $29.13M | $58.88M | $1.26M | $81.13M |